bpc-157 fda approved status Dosage Protocol: Injection Guide Rotator Cuff Injections

[1] As a compounded product, it is not an FDA-approved commercially manufactured drug

We need independent replication, longer follow-up and clear separation from product-driven claims

Product Details Form: Lyophilized powder (for laboratory research) Amounts: 6 mg BPC-157 + 6 mg TB-500 per vial OR 10 mg BPC-157 + 10 mg TB-500 per vial Purity: 98% (HPLC tested) BPC-157 Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 amino acids) Molecular Formula: CHNO Molecular Weight: ~1419.5 g/mol TB-500 Sequence (Thymosin Beta-4 fragment 1723): Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Lys-Thr-Glu-Thr (43 amino acids) Molecular Formula: CHNOS Molecular Weight: ~4963 Da Intended Use: Laboratory research only DISCLAIMER: This product is strictly to be used for scientific research use only

It is normally withdrawn, mixed with the drug, and then that mixture is injected (usually intramuscularly or subcutaneously, as indicated for the drug)

2012;35:e672e680

In short-bowel syndrome escalating throughout 4 weeks, the constant weight gain above preoperative values started immediately with peroral and parental BPC 157 therapy and the villus height, crypth depth and muscle thickness (inner (circular) muscular layer) additionally increased[3]